| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adolescent urologic oncology: Current issues and future directions
|
Cost, Nicholas G.
|
|
2014
|
32 |
2 |
p. 59-69
11 p.
|
artikel
|
| 2 |
Anticipating the effect of The Patient Protection and Affordable Care Act for patients with urologic cancer
|
Ellimoottil, Chandy
|
|
2014
|
32 |
2 |
p. 55-58
4 p.
|
artikel
|
| 3 |
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models
|
Fujita, Tetsuo
|
|
2014
|
32 |
2 |
p. 92-100
9 p.
|
artikel
|
| 4 |
Combining routine morphology, p16INK4a immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: A tissue microarray study using classifier performance analyses
|
Chaux, Alcides
|
|
2014
|
32 |
2 |
p. 171-177
7 p.
|
artikel
|
| 5 |
Commentary on “Age-related alterations in T-lymphocytes modulate key pathways in prostate tumorigenesis.” De Angulo A, Faris R, Cavazos D, Jolly C, Daniel B, DeGraffenried L, Department of Nutritional Sciences, Dell Pediatric Research Institute, University of Texas, Austin, TX, USA.
|
Olumi, Aria F.
|
|
2014
|
32 |
2 |
p. 212-213
2 p.
|
artikel
|
| 6 |
Commentary on “Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer.” Szarvas T, Jäger T, Laszlo V, Kramer G, Klingler HC, vom Dorp F, Romics I, Ergün S, Rübben H, Department of Urology, University of Duisburg-Essen, Germany.
|
Scherr, Douglas S.
|
|
2014
|
32 |
2 |
p. 215-
1 p.
|
artikel
|
| 7 |
Commentary on “Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder Cancer.” Garcia-Closas M, Rothman N, Figueroa JD, Prokunina-Olsson L, Han SS, Baris D, Jacobs EJ, Malats N, De Vivo I, Albanes D, Purdue MP, Sharma S, Fu YP, Kogevinas M, Wang Z, Tang W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr., Grubb R 3rd, Black A, Gapstur SM, Thun M, Diver WR, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Hutchinson A, Burdett L, Jacobs KB, Yeager M, Fraumeni JF Jr., Chanock SJ, Silverman DT, Chatterjee N, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
|
Scherr, Douglas S.
|
|
2014
|
32 |
2 |
p. 213-214
2 p.
|
artikel
|
| 8 |
Commentary on “ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.” Baena E, Shao Z, Linn DE, Glass K, Hamblen MJ, Fujiwara Y, Kim J, Nguyen M, Zhang X, Godinho FJ, Bronson RT, Mucci LA, Loda M, Yuan GC, Orkin SH, Li Z, Division of Hematology and Oncology, Boston Children's Hospital, Boston, MA, USA.
|
Olumi, Aria F.
|
|
2014
|
32 |
2 |
p. 213-
1 p.
|
artikel
|
| 9 |
Commentary on “Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.” Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS–Cancer Research UK GWAS–ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study Collaborators; PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Kote-Jarai Z, Easton DF, The Institute of Cancer Research, Sutton, UK.
|
Olumi, Aria F.
|
|
2014
|
32 |
2 |
p. 211-
1 p.
|
artikel
|
| 10 |
Commentary on “Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.” Aizer AA, Chen MH, Hattangadi J, D'Amico AV. Harvard Radiation Oncology program, Boston, MA.
|
Ritter, Mark A.
|
|
2014
|
32 |
2 |
p. 208-209
2 p.
|
artikel
|
| 11 |
Commentary on “Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.” Weischenfeldt J, Simon R, Feuerbach L, Schlangen K, Weichenhan D, Minner S, Wuttig D, Warnatz HJ, Stehr H, Rausch T, Jäger N, Gu L, Bogatyrova O, Stütz AM, Claus R, Eils J, Eils R, Gerhäuser C, Huang PH, Hutter B, Kabbe R, Lawerenz C, Radomski S, Bartholomae CC, Fälth M, Gade S, Schmidt M, Amschler N, Haß T, Galal R, Gjoni J, Kuner R, Baer C, Masser S, von Kalle C, Zichner T, Benes V, Raeder B, Mader M, Amstislavskiy V, Avci M, Lehrach H, Parkhomchuk D, Sultan M, Burkhardt L, Graefen M, Huland H, Kluth M, Krohn A, Sirma H, Stumm L, Steurer S, Grupp K, Sültmann H, Sauter G, Plass C, Brors B, Yaspo ML, Korbel JO, Schlomm T, Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
|
Olumi, Aria F.
|
|
2014
|
32 |
2 |
p. 212-
1 p.
|
artikel
|
| 12 |
Commentary on “Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and Ki67 labeling in prostate cancer patients.” Wagner D, Trudel D, Van der Kwast T, Nonn L, Giangreco AA, Li D, Dias A, Cardoza M, Laszlo S, Hersey K, Klotz L, Finelli A, Fleshner N, Vieth R, Department of Nutritional Sciences, University of Toronto, Ontario, Canada.
|
Olumi, Aria F.
|
|
2014
|
32 |
2 |
p. 210-
1 p.
|
artikel
|
| 13 |
Commentary on “Secondary cancers after intensity-modulated radiotherapy, brachytherapy, and radical prostatectomy for the treatment of prostate cancer: Incidence and cause-specific survival outcomes according to the initial treatment intervention.” Zelefsky MJ, Pei X, Teslova T, Kuk D, Magsanoc JM, Kollmeier M, Cox B, Zhang Z. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.
|
Gottschalk, Alexander
|
|
2014
|
32 |
2 |
p. 209-
1 p.
|
artikel
|
| 14 |
Commentary on “The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.” Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA, Signal Transduction Program, Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.
|
Olumi, Aria F.
|
|
2014
|
32 |
2 |
p. 210-211
2 p.
|
artikel
|
| 15 |
Commentary on “Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis.” He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.
|
Scherr, Douglas S.
|
|
2014
|
32 |
2 |
p. 214-
1 p.
|
artikel
|
| 16 |
Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis
|
Mitra, Anirban P.
|
|
2014
|
32 |
2 |
p. 117-127
11 p.
|
artikel
|
| 17 |
Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway
|
Ji, Shi-Qi
|
|
2014
|
32 |
2 |
p. 153-161
9 p.
|
artikel
|
| 18 |
Editorial Board
|
|
|
2014
|
32 |
2 |
p. i-
1 p.
|
artikel
|
| 19 |
Essential elements of personalized medicine
|
Burke, Wylie
|
|
2014
|
32 |
2 |
p. 193-197
5 p.
|
artikel
|
| 20 |
Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma
|
Yao, Xin
|
|
2014
|
32 |
2 |
p. 162-170
9 p.
|
artikel
|
| 21 |
Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy
|
Fairey, Adrian S.
|
|
2014
|
32 |
2 |
p. 110-116
7 p.
|
artikel
|
| 22 |
Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma
|
Liu, Yuqing
|
|
2014
|
32 |
2 |
p. 146-152
7 p.
|
artikel
|
| 23 |
Information for Authors
|
|
|
2014
|
32 |
2 |
p. 216-
1 p.
|
artikel
|
| 24 |
Integrating genomics into clinical oncology: Ethical and social challenges from proponents of personalized medicine
|
McGowan, Michelle L.
|
|
2014
|
32 |
2 |
p. 187-192
6 p.
|
artikel
|
| 25 |
Just caring: Assessing the ethical and economic costs of personalized medicine
|
Fleck, Leonard M.
|
|
2014
|
32 |
2 |
p. 202-206
5 p.
|
artikel
|
| 26 |
Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era
|
Fairey, Adrian S.
|
|
2014
|
32 |
2 |
p. 85-91
7 p.
|
artikel
|
| 27 |
Masthead
|
|
|
2014
|
32 |
2 |
p. IFC-
1 p.
|
artikel
|
| 28 |
Personalized medicine: An introduction to the ethical challenges
|
Fleck, Leonard M.
|
|
2014
|
32 |
2 |
p. 186-
1 p.
|
artikel
|
| 29 |
Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: Results from an Italian biopsy cohort
|
De Nunzio, Cosimo
|
|
2014
|
32 |
2 |
p. 80-84
5 p.
|
artikel
|
| 30 |
Short telomeres and chromosome instability prior to histologic malignant progression and cytogenetic aneuploidy in papillary urothelial neoplasms
|
Izumiyama-Shimomura, Naotaka
|
|
2014
|
32 |
2 |
p. 135-145
11 p.
|
artikel
|
| 31 |
Survey Section Editorial Board
|
|
|
2014
|
32 |
2 |
p. 207-
1 p.
|
artikel
|
| 32 |
Table of Contents
|
|
|
2014
|
32 |
2 |
p. ii-iv
nvt p.
|
artikel
|
| 33 |
The role of lymph vessel density and lymphangiogenesis in metastatic tumor spread of nonseminomatous testicular germ cell tumors
|
Heinzelbecker, Julia
|
|
2014
|
32 |
2 |
p. 178-185
8 p.
|
artikel
|
| 34 |
The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia
|
Hirai, Kenichi
|
|
2014
|
32 |
2 |
p. 101-109
9 p.
|
artikel
|
| 35 |
Treatment options in castration-resistant prostate cancer: Current therapies and emerging docetaxel-based regimens
|
Saad, Fred
|
|
2014
|
32 |
2 |
p. 70-79
10 p.
|
artikel
|
| 36 |
“Use it or lose it” as an alternative approach to protect genetic privacy in personalized medicine
|
Wagner, Jennifer K.
|
|
2014
|
32 |
2 |
p. 198-201
4 p.
|
artikel
|
| 37 |
What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up
|
Buteau, Anna
|
|
2014
|
32 |
2 |
p. 128-134
7 p.
|
artikel
|
|
Tijdschrift beschrijving